Provention Bio Inc. [NASDAQ: PRVB] stock went on an upward path that rose over 5.46% on Tuesday, amounting to a one-week price increase of more than 25.23%. Over the last 12 months, PRVB stock rose by 44.63%. The average equity rating for PRVB stock is currently 1.70, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $731.46 million, with 47.70 million shares outstanding and 32.68 million shares in the current float. Compared to the average trading volume of 637.21K shares, PRVB stock reached a trading volume of 2678120 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Provention Bio Inc. [PRVB]:
H.C. Wainwright have made an estimate for Provention Bio Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on June 16, 2020. While these analysts kept the previous recommendation, RBC Capital Mkts raised their target price to Outperform. The new note on the price target was released on June 04, 2020, representing the official price target for Provention Bio Inc. stock. Previously, the target price had yet another raise to $29, while Oppenheimer analysts kept a Outperform rating on PRVB stock.
The Average True Range (ATR) for Provention Bio Inc. is set at 1.45 The Price to Book ratio for the last quarter was 11.03, with the Price to Cash per share for the same quarter was set at 1.72.
PRVB Stock Performance Analysis:
Provention Bio Inc. [PRVB] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 25.23. With this latest performance, PRVB shares gained by 23.81% in over the last four-week period, additionally plugging by 40.07% over the last 6 months – not to mention a rise of 44.63% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for PRVB stock in for the last two-week period is set at 63.85, with the RSI for the last a single of trading hit 67.31, and the three-weeks RSI is set at 62.45 for Provention Bio Inc. [PRVB]. The present Moving Average for the last 50 days of trading for this stock 12.36, while it was recorded at 14.82 for the last single week of trading, and 11.01 for the last 200 days.
Insight into Provention Bio Inc. Fundamentals:
Return on Total Capital for PRVB is now -62.58, given the latest momentum, and Return on Invested Capital for the company is -61.04. Return on Equity for this stock declined to -61.04, with Return on Assets sitting at -58.68.
Reflecting on the efficiency of the workforce at the company, Provention Bio Inc. [PRVB] managed to generate an average of -$2,278,158 per employee.Provention Bio Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 11.30 and a Current Ratio set at 11.30.
PRVB Stock EPS
With the latest financial reports released by the company, Provention Bio Inc. posted -0.32/share EPS, while the average EPS was predicted by analysts to be reported at -0.31/share.When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -3.20%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for PRVB.
Provention Bio Inc. [PRVB] Insider Position Details
There are presently around $164 million, or 25.10% of PRVB stock, in the hands of institutional investors. The top three institutional holders of PRVB stocks are: PERCEPTIVE ADVISORS LLC with ownership of 3,011,574, which is approximately 3.081% of the company’s market cap and around 10.80% of the total institutional ownership; VANGUARD GROUP INC, holding 1,412,609 shares of the stock with an approximate value of $22.01 million in PRVB stocks shares; and JOHNSON & JOHNSON INNOVATION – JJDC, INC., currently with $17.53 million in PRVB stock with ownership of nearly 0% of the company’s market capitalization.
Positions in Provention Bio Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 44 institutional holders increased their position in Provention Bio Inc. [NASDAQ:PRVB] by around 2,559,285 shares. Additionally, 34 investors decreased positions by around 824,277 shares, while 4 investors held positions by with 7,118,440 shares. The mentioned changes placed institutional holdings at 10,502,002 shares, according to the latest SEC report filing. PRVB stock had 24 new institutional investments in for a total of 1,041,727 shares, while 16 institutional investors sold positions of 281,111 shares during the same period.